DCM
LKFT

DAFNA Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

DAFNA Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.91M Hold
130,175
– – 0.89% 31
2025
Q4 		$4.26M Hold
130,175
– – 0.99% 25
2025
Q3 		$4.51M Hold
130,175
– – 1.11% 21
2025
Q2 		$3.64M Hold
130,175
– – 1.01% 25
2025
Q1 		$3.27M Hold
130,175
– – 0.93% 26
2024
Q4 		$3.58M Hold
130,175
– – 0.91% 28
2024
Q3 		$3.75M Hold
130,175
– – 0.89% 29
2024
Q2 		$3.23M Hold
130,175
– – 0.77% 32
2024
Q1 		$4.19M Hold
130,175
– – 0.95% 31
2023
Q4 		$5.29M Buy
130,175
+70,000
+116% +$2.58M 1.27% 25
2023
Q3 		$2.08M Buy
60,175
+7,500
+14% +$292K 0.65% 40
2023
Q2 		$2.14M Hold
52,675
– – 0.59% 40
2023
Q1 		$2.04M Hold
52,675
– – 0.61% 39
2022
Q4 		$2.34M Buy
52,675
+10,000
+23% +$421K 0.66% 42
2022
Q3 		$1.82M Hold
42,675
– – 0.49% 44
2022
Q2 		$2.38M Hold
42,675
– – 0.65% 41
2022
Q1 		$2.65M Hold
42,675
– – 0.69% 40
2021
Q4 		$2.35M Sell
42,675
-35,000
-45% -$1.83M 0.59% 37
2021
Q3 		$4.09M Hold
77,675
– – 1.08% 24
2021
Q2 		$5.35M Buy
77,675
+2,500
+3% +$191K 1.12% 24
2021
Q1 		$5.79M Sell
75,175
-5,200
-6% -$479K 1.37% 18
2020
Q4 		$7.96M Buy
80,375
+36,000
+81% +$4.4M 2.37% 7
2020
Q3 		$6.3M Hold
44,375
– – 2.05% 11
2020
Q2 		$8.76M Sell
44,375
-2,000
-4% -$414K 2.53% 9
2020
Q1 		$9.09M Sell
46,375
-625
-1% -$134K 3.79% 4
2019
Q4 		$9.72M Sell
47,000
-5,509
-10% -$1.02M 3.34% 6
2019
Q3 		$8.02M Hold
52,509
– – 3.01% 5
2019
Q2 		$6.77M Buy
52,509
+2,900
+6% +$344K 2.54% 7
2019
Q1 		$5.84M Buy
49,609
+8,000
+19% +$807K 2.52% 11
2018
Q4 		$3.82M Buy
41,609
+2,000
+5% +$203K 1.9% 17
2018
Q3 		$4.45M Sell
39,609
-1,000
-2% -$106K 1.83% 19
2018
Q2 		$3.74M Buy
40,609
+1,000
+3% +$97K 1.75% 19
2018
Q1 		$3.95M Hold
39,609
– – 1.92% 20
2017
Q4 		$3.71M Buy
39,609
+8,000
+25% +$757K 2% 19
2017
Q3 		$3.22M Sell
31,609
-7,000
-18% -$612K 2% 14
2017
Q2 		$2.95M Buy
38,609
+3,250
+9% +$273K 2.11% 10
2017
Q1 		$3.05M Sell
35,359
-30,709
-46% -$2.21M 2.58% 8
2016
Q4 		$4.24M Hold
66,068
– – 3.73% 5
2016
Q3 		$4.27M Buy
66,068
+2,500
+4% +$141K 2.98% 7
2016
Q2 		$3.53M Sell
63,568
-2,000
-3% -$101K 2.79% 10
2016
Q1 		$2.74M Buy
65,568
+35,568
+119% +$1.65M 2.37% 13
2015
Q4 		$1.89M Buy
30,000
+28,291
+1,655% +$1.45M 1.68% 17
2015
Q3 		$70K Buy
+1,709
New +$98.5K 0.07% 85

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DAFNA Capital Management's LKFT Position: Q1 2026 in Review

DAFNA Capital Management held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q1 2026 at 130,175 shares worth $3.91M. The position accounts for 0.89% of the portfolio, ranked #31.

DAFNA Capital Management first reported a position in LKFT in Q3 2015 and has held it in 43 quarters since. The position peaked at $9.72M in Q4 2019. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • DAFNA Capital Management held 130,175 shares of Lakefront Biotherapeutics American Depositary Shares worth $3.91M as of Q1 2026.
  • DAFNA Capital Management left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q1 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.89% of DAFNA Capital Management's portfolio in Q1 2026, its #31 holding.
  • DAFNA Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and has held it in 43 quarters since.
  • DAFNA Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $9.72M in Q4 2019.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on DAFNA Capital Management's 13F filing for Q1 2026, filed 15 May 2026.